DPOP is one of the few programs in the country, housed in a school of pharmacy, whose faculty have active research programs in the field of pharmaceutical outcomes and policy. Research in this area has grown considerably over the past decade. This increased interest has been stimulated by two primary factors:
- the rising cost of pharmaceuticals coupled with the need to justify this expenditure in terms of improved health outcomes, and
- increased recognition that medications can have deleterious effects as well as therapeutic benefits.
Recently, the implementation of Medicare Part D has placed the importance of pharmaceuticals, comparative effectiveness, and medication therapy management services at the forefront of debates on health-care reform. In order for pharmacy to become a key leader and stakeholder, it will need to train pharmaceutical scientists who can conduct scientifically rigorous studies that inform policy decisions. Such scientists should be anchored in important scientific, ethical, and professional issues. DPOP is exceptionally well positioned to take on this challenge.
The mission of the Division of Pharmaceutical Outcomes and Policy is to conduct high-impact pharmaceutical outcomes research, educate and train professional and graduate students, and engage in professional service.
To lead the nation, and be at the forefront globally, in advancing the quality of medication use and influencing pharmaceutical policy through high-impact research, education, and service that improves societal health.